Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

Pazzaglia PJ, Post RM, Ketter TA, Callahan AM, Marangell LB, Frye MA, George MS, Kimbrell TA, Leverich GS, Cora-Locatelli G, Luckenbaugh D.

J Clin Psychopharmacol. 1998 Oct;18(5):404-13.

PMID:
9790159
2.

Rational polypharmacy in the bipolar affective disorders.

Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.

Epilepsy Res Suppl. 1996;11:153-80. Review.

PMID:
9294735
3.

[Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].

Sarfati Y, Spadone C, Vanelle JM, Lôo H.

Encephale. 1996 Mar-Apr;22(2):149-53. Review. French.

PMID:
8706625
4.

Algorithm for the treatment of rapid cycling.

Yamada K.

Psychiatry Clin Neurosci. 1999 Oct;53 Suppl:S73-5. Review.

5.

Alternative approaches to refractory depression in bipolar illness.

Post RM, Leverich GS, Denicoff KD, Frye MA, Kimbrell TA, Dunn R.

Depress Anxiety. 1997;5(4):175-89. Review.

PMID:
9338110
6.

Algorithms for the pharmacotherapy of bipolar disorder.

Motohashi N.

Psychiatry Clin Neurosci. 1999 Oct;53 Suppl:S41-4. Review.

7.

Barbiturate anticonvulsants in refractory affective disorders.

Hayes SG.

Ann Clin Psychiatry. 1993 Mar;5(1):35-44. Review.

PMID:
8348197
8.

Calcium antagonists in manic-depressive illness.

Dubovsky SL.

Neuropsychobiology. 1993;27(3):184-92. Review.

PMID:
8232837
9.

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, Lane TA, Tunbridge EM, Geddes JR, Harrison PJ.

Mol Psychiatry. 2016 Oct;21(10):1324-32. doi: 10.1038/mp.2016.86. Epub 2016 May 31. Review.

Supplemental Content

Support Center